VCIM
KPRX icon

Velan Capital Investment Management’s Kiora Pharmaceuticals KPRX Stock Holding History

Velan Capital Investment Management’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-122,223
Closed -$352K – 53
2025
Q2 		$352K Hold
122,223
– – 0.35% 28
2025
Q1 		$368K Hold
122,223
– – 0.38% 27
2024
Q4 		$403K Hold
122,223
– – 0.35% 21
2024
Q3 		$447K Hold
122,223
– – 0.42% 17
2024
Q2 		$513K Buy
122,223
+1
+0% +$5 0.29% 15
2024
Q1 		$777K Buy
+122,222
New +$683K 0.35% 20

Other funds holding KPRX

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Velan Capital Investment Management's KPRX Position: Q3 2025 in Review

Velan Capital Investment Management sold out of Kiora Pharmaceuticals (KPRX) in Q3 2025, closing a stake of 122,223 shares — an estimated $352K sold.

Velan Capital Investment Management first reported a position in KPRX in Q1 2024 and held it in 6 quarters. The position peaked at $777K in Q1 2024. 17 funds tracked by Wall St. Rank hold KPRX as of Q3 2025.

  • Velan Capital Investment Management reported no remaining Kiora Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Velan Capital Investment Management sold 122,223 Kiora Pharmaceuticals shares in Q3 2025, an estimated $352K.
  • Velan Capital Investment Management first reported a position in Kiora Pharmaceuticals in Q1 2024 and held it in 6 quarters.
  • Velan Capital Investment Management's Kiora Pharmaceuticals position peaked at $777K in Q1 2024.
  • 17 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q3 2025.

Based on Velan Capital Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.